BackArrowhead Pharmaceuticals Overview

Arrowhead Pharmaceuticals Selling, General & Admin

Selling, General & Admin expenses for ARWR.

Quarterly SG&A Expenses

$41.74M
↑ 46.96% YoY

As of Mar 31, 2026

Annual SG&A Expenses (TTM)

$155.89M
↑ 49.46% YoY

Trailing 12 months ending Mar 31, 2026

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin